nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP2C9—Bexarotene—hematologic cancer	0.0462	0.0817	CbGbCtD
Glipizide—CYP2C9—Idarubicin—hematologic cancer	0.0383	0.0677	CbGbCtD
Glipizide—CYP2C9—Bortezomib—hematologic cancer	0.0283	0.0501	CbGbCtD
Glipizide—CYP3A4—Bexarotene—hematologic cancer	0.0269	0.0475	CbGbCtD
Glipizide—CYP3A4—Busulfan—hematologic cancer	0.025	0.0442	CbGbCtD
Glipizide—CYP3A4—Lomustine—hematologic cancer	0.025	0.0442	CbGbCtD
Glipizide—CYP2C9—Thalidomide—hematologic cancer	0.0247	0.0436	CbGbCtD
Glipizide—CYP2C9—Teniposide—hematologic cancer	0.0235	0.0416	CbGbCtD
Glipizide—CYP3A4—Thiotepa—hematologic cancer	0.0223	0.0394	CbGbCtD
Glipizide—CYP2C9—Ifosfamide—hematologic cancer	0.0217	0.0384	CbGbCtD
Glipizide—CYP2C9—Imatinib—hematologic cancer	0.0207	0.0367	CbGbCtD
Glipizide—CYP2C9—Nilotinib—hematologic cancer	0.0189	0.0333	CbGbCtD
Glipizide—CYP3A4—Methoxsalen—hematologic cancer	0.0173	0.0306	CbGbCtD
Glipizide—CYP3A4—Bortezomib—hematologic cancer	0.0165	0.0291	CbGbCtD
Glipizide—CYP3A4—Daunorubicin—hematologic cancer	0.0157	0.0278	CbGbCtD
Glipizide—CYP3A4—Cytarabine—hematologic cancer	0.0139	0.0246	CbGbCtD
Glipizide—CYP3A4—Teniposide—hematologic cancer	0.0137	0.0242	CbGbCtD
Glipizide—CYP3A4—Ifosfamide—hematologic cancer	0.0126	0.0223	CbGbCtD
Glipizide—CYP3A4—Imatinib—hematologic cancer	0.0121	0.0213	CbGbCtD
Glipizide—CYP3A4—Ruxolitinib—hematologic cancer	0.0114	0.0201	CbGbCtD
Glipizide—CYP3A4—Nilotinib—hematologic cancer	0.011	0.0194	CbGbCtD
Glipizide—CYP3A4—Vinorelbine—hematologic cancer	0.0109	0.0192	CbGbCtD
Glipizide—CYP2C9—Cisplatin—hematologic cancer	0.0106	0.0187	CbGbCtD
Glipizide—CYP3A4—Triamcinolone—hematologic cancer	0.00994	0.0176	CbGbCtD
Glipizide—CYP3A4—Dasatinib—hematologic cancer	0.00969	0.0171	CbGbCtD
Glipizide—CYP3A4—Mitoxantrone—hematologic cancer	0.00957	0.0169	CbGbCtD
Glipizide—CYP2C9—Dexamethasone—hematologic cancer	0.00853	0.0151	CbGbCtD
Glipizide—CYP3A4—Betamethasone—hematologic cancer	0.00853	0.0151	CbGbCtD
Glipizide—CYP3A4—Prednisolone—hematologic cancer	0.00842	0.0149	CbGbCtD
Glipizide—CYP3A4—Prednisone—hematologic cancer	0.00795	0.0141	CbGbCtD
Glipizide—CYP3A4—Irinotecan—hematologic cancer	0.00753	0.0133	CbGbCtD
Glipizide—CYP3A4—Vinblastine—hematologic cancer	0.0067	0.0118	CbGbCtD
Glipizide—CYP3A4—Vincristine—hematologic cancer	0.00659	0.0116	CbGbCtD
Glipizide—CYP3A4—Etoposide—hematologic cancer	0.00603	0.0107	CbGbCtD
Glipizide—CYP3A4—Dexamethasone—hematologic cancer	0.00496	0.00877	CbGbCtD
Glipizide—CYP3A4—Doxorubicin—hematologic cancer	0.00412	0.00728	CbGbCtD
Glipizide—PPARG—Ponatinib—Nilotinib—hematologic cancer	0.00165	0.285	CbGdCrCtD
Glipizide—PPARG—Ponatinib—Imatinib—hematologic cancer	0.00125	0.216	CbGdCrCtD
Glipizide—PPARG—Topotecan—Irinotecan—hematologic cancer	0.00118	0.204	CbGdCrCtD
Glipizide—PPARG—Etoposide—Teniposide—hematologic cancer	0.00118	0.203	CbGdCrCtD
Glipizide—Gliclazide—VEGFA—hematologic cancer	0.00107	0.366	CrCbGaD
Glipizide—Glyburide—ABCC3—hematologic cancer	0.000713	0.244	CrCbGaD
Glipizide—PPARG—Teniposide—Etoposide—hematologic cancer	0.000534	0.0921	CbGdCrCtD
Glipizide—Glyburide—ABCG2—hematologic cancer	0.000346	0.118	CrCbGaD
Glipizide—Gliclazide—ALB—hematologic cancer	0.000288	0.0983	CrCbGaD
Glipizide—Chlorpropamide—ABCB1—hematologic cancer	0.000213	0.073	CrCbGaD
Glipizide—Glyburide—ALB—hematologic cancer	0.000151	0.0516	CrCbGaD
Glipizide—Glyburide—ABCB1—hematologic cancer	0.000144	0.0493	CrCbGaD
Glipizide—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	5.74e-05	0.000176	CcSEcCtD
Glipizide—Arthralgia—Prednisone—hematologic cancer	5.73e-05	0.000175	CcSEcCtD
Glipizide—Myalgia—Prednisone—hematologic cancer	5.73e-05	0.000175	CcSEcCtD
Glipizide—Feeling abnormal—Triamcinolone—hematologic cancer	5.72e-05	0.000175	CcSEcCtD
Glipizide—Diarrhoea—Cisplatin—hematologic cancer	5.72e-05	0.000175	CcSEcCtD
Glipizide—Anxiety—Prednisone—hematologic cancer	5.71e-05	0.000175	CcSEcCtD
Glipizide—Vomiting—Gemcitabine—hematologic cancer	5.7e-05	0.000175	CcSEcCtD
Glipizide—Insomnia—Betamethasone—hematologic cancer	5.7e-05	0.000175	CcSEcCtD
Glipizide—Insomnia—Dexamethasone—hematologic cancer	5.7e-05	0.000175	CcSEcCtD
Glipizide—Paraesthesia—Betamethasone—hematologic cancer	5.66e-05	0.000173	CcSEcCtD
Glipizide—Paraesthesia—Dexamethasone—hematologic cancer	5.66e-05	0.000173	CcSEcCtD
Glipizide—Discomfort—Prednisone—hematologic cancer	5.66e-05	0.000173	CcSEcCtD
Glipizide—Rash—Gemcitabine—hematologic cancer	5.66e-05	0.000173	CcSEcCtD
Glipizide—Dermatitis—Gemcitabine—hematologic cancer	5.65e-05	0.000173	CcSEcCtD
Glipizide—Eye disorder—Epirubicin—hematologic cancer	5.65e-05	0.000173	CcSEcCtD
Glipizide—Hypersensitivity—Etoposide—hematologic cancer	5.64e-05	0.000173	CcSEcCtD
Glipizide—Erythema—Methotrexate—hematologic cancer	5.62e-05	0.000172	CcSEcCtD
Glipizide—Headache—Gemcitabine—hematologic cancer	5.62e-05	0.000172	CcSEcCtD
Glipizide—Nausea—Vincristine—hematologic cancer	5.62e-05	0.000172	CcSEcCtD
Glipizide—Flushing—Epirubicin—hematologic cancer	5.61e-05	0.000172	CcSEcCtD
Glipizide—Rhinitis—Doxorubicin—hematologic cancer	5.61e-05	0.000172	CcSEcCtD
Glipizide—Hepatitis—Doxorubicin—hematologic cancer	5.59e-05	0.000171	CcSEcCtD
Glipizide—Hypersensitivity—Prednisolone—hematologic cancer	5.57e-05	0.00017	CcSEcCtD
Glipizide—Hypoaesthesia—Doxorubicin—hematologic cancer	5.56e-05	0.00017	CcSEcCtD
Glipizide—Pharyngitis—Doxorubicin—hematologic cancer	5.55e-05	0.00017	CcSEcCtD
Glipizide—Dyspepsia—Betamethasone—hematologic cancer	5.55e-05	0.00017	CcSEcCtD
Glipizide—Dyspepsia—Dexamethasone—hematologic cancer	5.55e-05	0.00017	CcSEcCtD
Glipizide—Urticaria—Triamcinolone—hematologic cancer	5.52e-05	0.000169	CcSEcCtD
Glipizide—Asthenia—Etoposide—hematologic cancer	5.5e-05	0.000168	CcSEcCtD
Glipizide—Oedema—Prednisone—hematologic cancer	5.49e-05	0.000168	CcSEcCtD
Glipizide—Decreased appetite—Dexamethasone—hematologic cancer	5.48e-05	0.000168	CcSEcCtD
Glipizide—Decreased appetite—Betamethasone—hematologic cancer	5.48e-05	0.000168	CcSEcCtD
Glipizide—Nausea—Mitoxantrone—hematologic cancer	5.47e-05	0.000167	CcSEcCtD
Glipizide—Nausea—Irinotecan—hematologic cancer	5.47e-05	0.000167	CcSEcCtD
Glipizide—Gastrointestinal disorder—Dexamethasone—hematologic cancer	5.44e-05	0.000167	CcSEcCtD
Glipizide—Gastrointestinal disorder—Betamethasone—hematologic cancer	5.44e-05	0.000167	CcSEcCtD
Glipizide—Chills—Epirubicin—hematologic cancer	5.42e-05	0.000166	CcSEcCtD
Glipizide—Pruritus—Etoposide—hematologic cancer	5.42e-05	0.000166	CcSEcCtD
Glipizide—Shock—Prednisone—hematologic cancer	5.4e-05	0.000165	CcSEcCtD
Glipizide—Arrhythmia—Epirubicin—hematologic cancer	5.4e-05	0.000165	CcSEcCtD
Glipizide—Pain—Dexamethasone—hematologic cancer	5.39e-05	0.000165	CcSEcCtD
Glipizide—Pain—Betamethasone—hematologic cancer	5.39e-05	0.000165	CcSEcCtD
Glipizide—Visual impairment—Doxorubicin—hematologic cancer	5.39e-05	0.000165	CcSEcCtD
Glipizide—Nausea—Gemcitabine—hematologic cancer	5.33e-05	0.000163	CcSEcCtD
Glipizide—Vomiting—Cisplatin—hematologic cancer	5.32e-05	0.000163	CcSEcCtD
Glipizide—Hyperhidrosis—Prednisone—hematologic cancer	5.31e-05	0.000163	CcSEcCtD
Glipizide—Vision blurred—Methotrexate—hematologic cancer	5.3e-05	0.000162	CcSEcCtD
Glipizide—Rash—Cisplatin—hematologic cancer	5.27e-05	0.000161	CcSEcCtD
Glipizide—Dermatitis—Cisplatin—hematologic cancer	5.27e-05	0.000161	CcSEcCtD
Glipizide—Erythema—Epirubicin—hematologic cancer	5.26e-05	0.000161	CcSEcCtD
Glipizide—Diarrhoea—Etoposide—hematologic cancer	5.24e-05	0.00016	CcSEcCtD
Glipizide—Anorexia—Prednisone—hematologic cancer	5.23e-05	0.00016	CcSEcCtD
Glipizide—Eye disorder—Doxorubicin—hematologic cancer	5.23e-05	0.00016	CcSEcCtD
Glipizide—Ill-defined disorder—Methotrexate—hematologic cancer	5.22e-05	0.00016	CcSEcCtD
Glipizide—Feeling abnormal—Dexamethasone—hematologic cancer	5.19e-05	0.000159	CcSEcCtD
Glipizide—Feeling abnormal—Betamethasone—hematologic cancer	5.19e-05	0.000159	CcSEcCtD
Glipizide—Flushing—Doxorubicin—hematologic cancer	5.19e-05	0.000159	CcSEcCtD
Glipizide—Flatulence—Epirubicin—hematologic cancer	5.18e-05	0.000159	CcSEcCtD
Glipizide—Tension—Epirubicin—hematologic cancer	5.16e-05	0.000158	CcSEcCtD
Glipizide—Gastrointestinal pain—Dexamethasone—hematologic cancer	5.15e-05	0.000158	CcSEcCtD
Glipizide—Gastrointestinal pain—Betamethasone—hematologic cancer	5.15e-05	0.000158	CcSEcCtD
Glipizide—Hypersensitivity—Triamcinolone—hematologic cancer	5.12e-05	0.000157	CcSEcCtD
Glipizide—Nervousness—Epirubicin—hematologic cancer	5.11e-05	0.000156	CcSEcCtD
Glipizide—Malaise—Methotrexate—hematologic cancer	5.07e-05	0.000155	CcSEcCtD
Glipizide—Dizziness—Etoposide—hematologic cancer	5.06e-05	0.000155	CcSEcCtD
Glipizide—Muscle spasms—Epirubicin—hematologic cancer	5.06e-05	0.000155	CcSEcCtD
Glipizide—Vertigo—Methotrexate—hematologic cancer	5.05e-05	0.000155	CcSEcCtD
Glipizide—Leukopenia—Methotrexate—hematologic cancer	5.03e-05	0.000154	CcSEcCtD
Glipizide—Chills—Doxorubicin—hematologic cancer	5.02e-05	0.000154	CcSEcCtD
Glipizide—Urticaria—Betamethasone—hematologic cancer	5.01e-05	0.000153	CcSEcCtD
Glipizide—Urticaria—Dexamethasone—hematologic cancer	5.01e-05	0.000153	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Prednisone—hematologic cancer	5e-05	0.000153	CcSEcCtD
Glipizide—Dizziness—Prednisolone—hematologic cancer	5e-05	0.000153	CcSEcCtD
Glipizide—Arrhythmia—Doxorubicin—hematologic cancer	5e-05	0.000153	CcSEcCtD
Glipizide—Asthenia—Triamcinolone—hematologic cancer	4.98e-05	0.000153	CcSEcCtD
Glipizide—Abdominal pain—Betamethasone—hematologic cancer	4.98e-05	0.000153	CcSEcCtD
Glipizide—Abdominal pain—Dexamethasone—hematologic cancer	4.98e-05	0.000153	CcSEcCtD
Glipizide—Nausea—Cisplatin—hematologic cancer	4.97e-05	0.000152	CcSEcCtD
Glipizide—Insomnia—Prednisone—hematologic cancer	4.96e-05	0.000152	CcSEcCtD
Glipizide—Vision blurred—Epirubicin—hematologic cancer	4.96e-05	0.000152	CcSEcCtD
Glipizide—Paraesthesia—Prednisone—hematologic cancer	4.93e-05	0.000151	CcSEcCtD
Glipizide—Pruritus—Triamcinolone—hematologic cancer	4.91e-05	0.000151	CcSEcCtD
Glipizide—Ill-defined disorder—Epirubicin—hematologic cancer	4.88e-05	0.000149	CcSEcCtD
Glipizide—Vomiting—Etoposide—hematologic cancer	4.87e-05	0.000149	CcSEcCtD
Glipizide—Erythema—Doxorubicin—hematologic cancer	4.87e-05	0.000149	CcSEcCtD
Glipizide—Dyspepsia—Prednisone—hematologic cancer	4.83e-05	0.000148	CcSEcCtD
Glipizide—Rash—Etoposide—hematologic cancer	4.83e-05	0.000148	CcSEcCtD
Glipizide—Dermatitis—Etoposide—hematologic cancer	4.82e-05	0.000148	CcSEcCtD
Glipizide—Headache—Etoposide—hematologic cancer	4.8e-05	0.000147	CcSEcCtD
Glipizide—Flatulence—Doxorubicin—hematologic cancer	4.8e-05	0.000147	CcSEcCtD
Glipizide—Arthralgia—Methotrexate—hematologic cancer	4.79e-05	0.000147	CcSEcCtD
Glipizide—Myalgia—Methotrexate—hematologic cancer	4.79e-05	0.000147	CcSEcCtD
Glipizide—Tension—Doxorubicin—hematologic cancer	4.78e-05	0.000146	CcSEcCtD
Glipizide—Decreased appetite—Prednisone—hematologic cancer	4.77e-05	0.000146	CcSEcCtD
Glipizide—Rash—Prednisolone—hematologic cancer	4.76e-05	0.000146	CcSEcCtD
Glipizide—Dermatitis—Prednisolone—hematologic cancer	4.76e-05	0.000146	CcSEcCtD
Glipizide—Malaise—Epirubicin—hematologic cancer	4.74e-05	0.000145	CcSEcCtD
Glipizide—Headache—Prednisolone—hematologic cancer	4.73e-05	0.000145	CcSEcCtD
Glipizide—Discomfort—Methotrexate—hematologic cancer	4.73e-05	0.000145	CcSEcCtD
Glipizide—Nervousness—Doxorubicin—hematologic cancer	4.73e-05	0.000145	CcSEcCtD
Glipizide—Vertigo—Epirubicin—hematologic cancer	4.73e-05	0.000145	CcSEcCtD
Glipizide—Syncope—Epirubicin—hematologic cancer	4.72e-05	0.000144	CcSEcCtD
Glipizide—Leukopenia—Epirubicin—hematologic cancer	4.71e-05	0.000144	CcSEcCtD
Glipizide—Constipation—Prednisone—hematologic cancer	4.69e-05	0.000144	CcSEcCtD
Glipizide—Muscle spasms—Doxorubicin—hematologic cancer	4.68e-05	0.000143	CcSEcCtD
Glipizide—Confusional state—Methotrexate—hematologic cancer	4.63e-05	0.000142	CcSEcCtD
Glipizide—Loss of consciousness—Epirubicin—hematologic cancer	4.62e-05	0.000142	CcSEcCtD
Glipizide—Dizziness—Triamcinolone—hematologic cancer	4.59e-05	0.000141	CcSEcCtD
Glipizide—Vision blurred—Doxorubicin—hematologic cancer	4.59e-05	0.00014	CcSEcCtD
Glipizide—Nausea—Etoposide—hematologic cancer	4.55e-05	0.000139	CcSEcCtD
Glipizide—Hypertension—Epirubicin—hematologic cancer	4.54e-05	0.000139	CcSEcCtD
Glipizide—Feeling abnormal—Prednisone—hematologic cancer	4.52e-05	0.000139	CcSEcCtD
Glipizide—Asthenia—Dexamethasone—hematologic cancer	4.52e-05	0.000138	CcSEcCtD
Glipizide—Asthenia—Betamethasone—hematologic cancer	4.52e-05	0.000138	CcSEcCtD
Glipizide—Ill-defined disorder—Doxorubicin—hematologic cancer	4.52e-05	0.000138	CcSEcCtD
Glipizide—Thrombocytopenia—Methotrexate—hematologic cancer	4.49e-05	0.000138	CcSEcCtD
Glipizide—Gastrointestinal pain—Prednisone—hematologic cancer	4.49e-05	0.000137	CcSEcCtD
Glipizide—Nausea—Prednisolone—hematologic cancer	4.49e-05	0.000137	CcSEcCtD
Glipizide—Arthralgia—Epirubicin—hematologic cancer	4.48e-05	0.000137	CcSEcCtD
Glipizide—Myalgia—Epirubicin—hematologic cancer	4.48e-05	0.000137	CcSEcCtD
Glipizide—Anxiety—Epirubicin—hematologic cancer	4.46e-05	0.000137	CcSEcCtD
Glipizide—Pruritus—Dexamethasone—hematologic cancer	4.46e-05	0.000137	CcSEcCtD
Glipizide—Pruritus—Betamethasone—hematologic cancer	4.46e-05	0.000137	CcSEcCtD
Glipizide—Hyperhidrosis—Methotrexate—hematologic cancer	4.44e-05	0.000136	CcSEcCtD
Glipizide—Discomfort—Epirubicin—hematologic cancer	4.42e-05	0.000136	CcSEcCtD
Glipizide—Vomiting—Triamcinolone—hematologic cancer	4.42e-05	0.000135	CcSEcCtD
Glipizide—Malaise—Doxorubicin—hematologic cancer	4.39e-05	0.000134	CcSEcCtD
Glipizide—Rash—Triamcinolone—hematologic cancer	4.38e-05	0.000134	CcSEcCtD
Glipizide—Dermatitis—Triamcinolone—hematologic cancer	4.38e-05	0.000134	CcSEcCtD
Glipizide—Vertigo—Doxorubicin—hematologic cancer	4.37e-05	0.000134	CcSEcCtD
Glipizide—Anorexia—Methotrexate—hematologic cancer	4.37e-05	0.000134	CcSEcCtD
Glipizide—Syncope—Doxorubicin—hematologic cancer	4.36e-05	0.000134	CcSEcCtD
Glipizide—Urticaria—Prednisone—hematologic cancer	4.36e-05	0.000134	CcSEcCtD
Glipizide—Leukopenia—Doxorubicin—hematologic cancer	4.36e-05	0.000133	CcSEcCtD
Glipizide—Headache—Triamcinolone—hematologic cancer	4.35e-05	0.000133	CcSEcCtD
Glipizide—Abdominal pain—Prednisone—hematologic cancer	4.34e-05	0.000133	CcSEcCtD
Glipizide—Confusional state—Epirubicin—hematologic cancer	4.33e-05	0.000133	CcSEcCtD
Glipizide—Diarrhoea—Betamethasone—hematologic cancer	4.31e-05	0.000132	CcSEcCtD
Glipizide—Diarrhoea—Dexamethasone—hematologic cancer	4.31e-05	0.000132	CcSEcCtD
Glipizide—Oedema—Epirubicin—hematologic cancer	4.29e-05	0.000131	CcSEcCtD
Glipizide—Loss of consciousness—Doxorubicin—hematologic cancer	4.28e-05	0.000131	CcSEcCtD
Glipizide—Shock—Epirubicin—hematologic cancer	4.22e-05	0.000129	CcSEcCtD
Glipizide—Thrombocytopenia—Epirubicin—hematologic cancer	4.2e-05	0.000129	CcSEcCtD
Glipizide—Hypertension—Doxorubicin—hematologic cancer	4.2e-05	0.000129	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Methotrexate—hematologic cancer	4.18e-05	0.000128	CcSEcCtD
Glipizide—Dizziness—Betamethasone—hematologic cancer	4.17e-05	0.000128	CcSEcCtD
Glipizide—Dizziness—Dexamethasone—hematologic cancer	4.17e-05	0.000128	CcSEcCtD
Glipizide—Hyperhidrosis—Epirubicin—hematologic cancer	4.15e-05	0.000127	CcSEcCtD
Glipizide—Insomnia—Methotrexate—hematologic cancer	4.15e-05	0.000127	CcSEcCtD
Glipizide—Myalgia—Doxorubicin—hematologic cancer	4.14e-05	0.000127	CcSEcCtD
Glipizide—Arthralgia—Doxorubicin—hematologic cancer	4.14e-05	0.000127	CcSEcCtD
Glipizide—Anxiety—Doxorubicin—hematologic cancer	4.13e-05	0.000126	CcSEcCtD
Glipizide—Nausea—Triamcinolone—hematologic cancer	4.13e-05	0.000126	CcSEcCtD
Glipizide—Paraesthesia—Methotrexate—hematologic cancer	4.12e-05	0.000126	CcSEcCtD
Glipizide—Discomfort—Doxorubicin—hematologic cancer	4.09e-05	0.000125	CcSEcCtD
Glipizide—Anorexia—Epirubicin—hematologic cancer	4.09e-05	0.000125	CcSEcCtD
Glipizide—Dyspnoea—Methotrexate—hematologic cancer	4.09e-05	0.000125	CcSEcCtD
Glipizide—Somnolence—Methotrexate—hematologic cancer	4.08e-05	0.000125	CcSEcCtD
Glipizide—Hypersensitivity—Prednisone—hematologic cancer	4.04e-05	0.000124	CcSEcCtD
Glipizide—Dyspepsia—Methotrexate—hematologic cancer	4.04e-05	0.000124	CcSEcCtD
Glipizide—Vomiting—Betamethasone—hematologic cancer	4.01e-05	0.000123	CcSEcCtD
Glipizide—Vomiting—Dexamethasone—hematologic cancer	4.01e-05	0.000123	CcSEcCtD
Glipizide—Confusional state—Doxorubicin—hematologic cancer	4.01e-05	0.000123	CcSEcCtD
Glipizide—Decreased appetite—Methotrexate—hematologic cancer	3.99e-05	0.000122	CcSEcCtD
Glipizide—Rash—Dexamethasone—hematologic cancer	3.97e-05	0.000122	CcSEcCtD
Glipizide—Rash—Betamethasone—hematologic cancer	3.97e-05	0.000122	CcSEcCtD
Glipizide—Oedema—Doxorubicin—hematologic cancer	3.97e-05	0.000122	CcSEcCtD
Glipizide—Dermatitis—Dexamethasone—hematologic cancer	3.97e-05	0.000122	CcSEcCtD
Glipizide—Dermatitis—Betamethasone—hematologic cancer	3.97e-05	0.000122	CcSEcCtD
Glipizide—Gastrointestinal disorder—Methotrexate—hematologic cancer	3.96e-05	0.000121	CcSEcCtD
Glipizide—Headache—Betamethasone—hematologic cancer	3.95e-05	0.000121	CcSEcCtD
Glipizide—Headache—Dexamethasone—hematologic cancer	3.95e-05	0.000121	CcSEcCtD
Glipizide—Asthenia—Prednisone—hematologic cancer	3.94e-05	0.000121	CcSEcCtD
Glipizide—Pain—Methotrexate—hematologic cancer	3.92e-05	0.00012	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Epirubicin—hematologic cancer	3.91e-05	0.00012	CcSEcCtD
Glipizide—Shock—Doxorubicin—hematologic cancer	3.91e-05	0.00012	CcSEcCtD
Glipizide—Thrombocytopenia—Doxorubicin—hematologic cancer	3.89e-05	0.000119	CcSEcCtD
Glipizide—Pruritus—Prednisone—hematologic cancer	3.88e-05	0.000119	CcSEcCtD
Glipizide—Insomnia—Epirubicin—hematologic cancer	3.88e-05	0.000119	CcSEcCtD
Glipizide—Paraesthesia—Epirubicin—hematologic cancer	3.86e-05	0.000118	CcSEcCtD
Glipizide—Hyperhidrosis—Doxorubicin—hematologic cancer	3.84e-05	0.000118	CcSEcCtD
Glipizide—Dyspnoea—Epirubicin—hematologic cancer	3.83e-05	0.000117	CcSEcCtD
Glipizide—Somnolence—Epirubicin—hematologic cancer	3.82e-05	0.000117	CcSEcCtD
Glipizide—Anorexia—Doxorubicin—hematologic cancer	3.79e-05	0.000116	CcSEcCtD
Glipizide—Feeling abnormal—Methotrexate—hematologic cancer	3.78e-05	0.000116	CcSEcCtD
Glipizide—Dyspepsia—Epirubicin—hematologic cancer	3.78e-05	0.000116	CcSEcCtD
Glipizide—Diarrhoea—Prednisone—hematologic cancer	3.76e-05	0.000115	CcSEcCtD
Glipizide—Gastrointestinal pain—Methotrexate—hematologic cancer	3.75e-05	0.000115	CcSEcCtD
Glipizide—Nausea—Betamethasone—hematologic cancer	3.74e-05	0.000115	CcSEcCtD
Glipizide—Nausea—Dexamethasone—hematologic cancer	3.74e-05	0.000115	CcSEcCtD
Glipizide—Decreased appetite—Epirubicin—hematologic cancer	3.73e-05	0.000114	CcSEcCtD
Glipizide—Gastrointestinal disorder—Epirubicin—hematologic cancer	3.71e-05	0.000114	CcSEcCtD
Glipizide—Constipation—Epirubicin—hematologic cancer	3.67e-05	0.000112	CcSEcCtD
Glipizide—Pain—Epirubicin—hematologic cancer	3.67e-05	0.000112	CcSEcCtD
Glipizide—Urticaria—Methotrexate—hematologic cancer	3.64e-05	0.000112	CcSEcCtD
Glipizide—Dizziness—Prednisone—hematologic cancer	3.63e-05	0.000111	CcSEcCtD
Glipizide—Abdominal pain—Methotrexate—hematologic cancer	3.63e-05	0.000111	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	3.62e-05	0.000111	CcSEcCtD
Glipizide—Insomnia—Doxorubicin—hematologic cancer	3.59e-05	0.00011	CcSEcCtD
Glipizide—Paraesthesia—Doxorubicin—hematologic cancer	3.57e-05	0.000109	CcSEcCtD
Glipizide—Dyspnoea—Doxorubicin—hematologic cancer	3.54e-05	0.000108	CcSEcCtD
Glipizide—Feeling abnormal—Epirubicin—hematologic cancer	3.54e-05	0.000108	CcSEcCtD
Glipizide—Somnolence—Doxorubicin—hematologic cancer	3.53e-05	0.000108	CcSEcCtD
Glipizide—Gastrointestinal pain—Epirubicin—hematologic cancer	3.51e-05	0.000108	CcSEcCtD
Glipizide—Dyspepsia—Doxorubicin—hematologic cancer	3.5e-05	0.000107	CcSEcCtD
Glipizide—Vomiting—Prednisone—hematologic cancer	3.49e-05	0.000107	CcSEcCtD
Glipizide—Rash—Prednisone—hematologic cancer	3.46e-05	0.000106	CcSEcCtD
Glipizide—Dermatitis—Prednisone—hematologic cancer	3.46e-05	0.000106	CcSEcCtD
Glipizide—Decreased appetite—Doxorubicin—hematologic cancer	3.45e-05	0.000106	CcSEcCtD
Glipizide—Headache—Prednisone—hematologic cancer	3.44e-05	0.000105	CcSEcCtD
Glipizide—Gastrointestinal disorder—Doxorubicin—hematologic cancer	3.43e-05	0.000105	CcSEcCtD
Glipizide—Urticaria—Epirubicin—hematologic cancer	3.41e-05	0.000104	CcSEcCtD
Glipizide—Constipation—Doxorubicin—hematologic cancer	3.4e-05	0.000104	CcSEcCtD
Glipizide—Pain—Doxorubicin—hematologic cancer	3.4e-05	0.000104	CcSEcCtD
Glipizide—Abdominal pain—Epirubicin—hematologic cancer	3.39e-05	0.000104	CcSEcCtD
Glipizide—Hypersensitivity—Methotrexate—hematologic cancer	3.38e-05	0.000104	CcSEcCtD
Glipizide—Asthenia—Methotrexate—hematologic cancer	3.29e-05	0.000101	CcSEcCtD
Glipizide—Feeling abnormal—Doxorubicin—hematologic cancer	3.27e-05	0.0001	CcSEcCtD
Glipizide—Nausea—Prednisone—hematologic cancer	3.26e-05	9.99e-05	CcSEcCtD
Glipizide—Gastrointestinal pain—Doxorubicin—hematologic cancer	3.25e-05	9.95e-05	CcSEcCtD
Glipizide—Pruritus—Methotrexate—hematologic cancer	3.25e-05	9.94e-05	CcSEcCtD
Glipizide—ABCC8—Metabolism—NQO1—hematologic cancer	3.21e-05	0.000323	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALOX5—hematologic cancer	3.18e-05	0.000321	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—EZH2—hematologic cancer	3.17e-05	0.000319	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GMPS—hematologic cancer	3.17e-05	0.000319	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PHYH—hematologic cancer	3.17e-05	0.000319	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—FTCD—hematologic cancer	3.17e-05	0.000319	CbGpPWpGaD
Glipizide—Hypersensitivity—Epirubicin—hematologic cancer	3.16e-05	9.69e-05	CcSEcCtD
Glipizide—Urticaria—Doxorubicin—hematologic cancer	3.16e-05	9.66e-05	CcSEcCtD
Glipizide—Abdominal pain—Doxorubicin—hematologic cancer	3.14e-05	9.62e-05	CcSEcCtD
Glipizide—Diarrhoea—Methotrexate—hematologic cancer	3.14e-05	9.61e-05	CcSEcCtD
Glipizide—ABCC8—Neuronal System—HRAS—hematologic cancer	3.13e-05	0.000316	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	3.13e-05	0.000316	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CREB1—hematologic cancer	3.13e-05	0.000316	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NQO1—hematologic cancer	3.11e-05	0.000314	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CD44—hematologic cancer	3.11e-05	0.000314	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—PARP1—hematologic cancer	3.1e-05	0.000313	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NUP98—hematologic cancer	3.08e-05	0.000311	CbGpPWpGaD
Glipizide—Asthenia—Epirubicin—hematologic cancer	3.08e-05	9.43e-05	CcSEcCtD
Glipizide—PPARG—Developmental Biology—IL6R—hematologic cancer	3.06e-05	0.000308	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—TP53—hematologic cancer	3.05e-05	0.000308	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CREBBP—hematologic cancer	3.05e-05	0.000308	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—HRAS—hematologic cancer	3.04e-05	0.000306	CbGpPWpGaD
Glipizide—Pruritus—Epirubicin—hematologic cancer	3.04e-05	9.3e-05	CcSEcCtD
Glipizide—ABCC8—Metabolism—CYCS—hematologic cancer	3.04e-05	0.000306	CbGpPWpGaD
Glipizide—Dizziness—Methotrexate—hematologic cancer	3.03e-05	9.29e-05	CcSEcCtD
Glipizide—ABCC8—Metabolism—HSP90AA1—hematologic cancer	3.02e-05	0.000304	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—HDAC2—hematologic cancer	2.99e-05	0.000302	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ADCY7—hematologic cancer	2.99e-05	0.000301	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NCOA3—hematologic cancer	2.99e-05	0.000301	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	2.98e-05	0.000301	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NUP214—hematologic cancer	2.97e-05	0.000299	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	2.95e-05	0.000297	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYCS—hematologic cancer	2.94e-05	0.000297	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	2.94e-05	0.000296	CbGpPWpGaD
Glipizide—Diarrhoea—Epirubicin—hematologic cancer	2.94e-05	9e-05	CcSEcCtD
Glipizide—Hypersensitivity—Doxorubicin—hematologic cancer	2.93e-05	8.96e-05	CcSEcCtD
Glipizide—KCNJ11—Metabolism—HSP90AA1—hematologic cancer	2.93e-05	0.000295	CbGpPWpGaD
Glipizide—Vomiting—Methotrexate—hematologic cancer	2.92e-05	8.93e-05	CcSEcCtD
Glipizide—PPARG—Developmental Biology—MAP2K1—hematologic cancer	2.91e-05	0.000294	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ABCG2—hematologic cancer	2.91e-05	0.000293	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MTR—hematologic cancer	2.91e-05	0.000293	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SMPD3—hematologic cancer	2.89e-05	0.000292	CbGpPWpGaD
Glipizide—Rash—Methotrexate—hematologic cancer	2.89e-05	8.86e-05	CcSEcCtD
Glipizide—Dermatitis—Methotrexate—hematologic cancer	2.89e-05	8.85e-05	CcSEcCtD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	2.89e-05	0.000291	CbGpPWpGaD
Glipizide—Headache—Methotrexate—hematologic cancer	2.87e-05	8.8e-05	CcSEcCtD
Glipizide—PPARG—Metabolism—ENO2—hematologic cancer	2.85e-05	0.000288	CbGpPWpGaD
Glipizide—Asthenia—Doxorubicin—hematologic cancer	2.85e-05	8.73e-05	CcSEcCtD
Glipizide—Dizziness—Epirubicin—hematologic cancer	2.84e-05	8.69e-05	CcSEcCtD
Glipizide—Pruritus—Doxorubicin—hematologic cancer	2.81e-05	8.61e-05	CcSEcCtD
Glipizide—PPARG—Circadian rythm related genes—IL6—hematologic cancer	2.79e-05	0.000282	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—FGF2—hematologic cancer	2.77e-05	0.000279	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTT1—hematologic cancer	2.77e-05	0.000279	CbGpPWpGaD
Glipizide—Vomiting—Epirubicin—hematologic cancer	2.73e-05	8.36e-05	CcSEcCtD
Glipizide—Nausea—Methotrexate—hematologic cancer	2.73e-05	8.34e-05	CcSEcCtD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	2.72e-05	0.000275	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTP1—hematologic cancer	2.72e-05	0.000275	CbGpPWpGaD
Glipizide—Diarrhoea—Doxorubicin—hematologic cancer	2.72e-05	8.32e-05	CcSEcCtD
Glipizide—Rash—Epirubicin—hematologic cancer	2.71e-05	8.29e-05	CcSEcCtD
Glipizide—PPARG—Metabolism—SDC1—hematologic cancer	2.7e-05	0.000273	CbGpPWpGaD
Glipizide—Dermatitis—Epirubicin—hematologic cancer	2.7e-05	8.28e-05	CcSEcCtD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	2.7e-05	0.000272	CbGpPWpGaD
Glipizide—Headache—Epirubicin—hematologic cancer	2.69e-05	8.24e-05	CcSEcCtD
Glipizide—CYP3A4—Metapathway biotransformation—GSTP1—hematologic cancer	2.69e-05	0.000271	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTP1—hematologic cancer	2.68e-05	0.00027	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—JAK2—hematologic cancer	2.66e-05	0.000268	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	2.63e-05	0.000265	CbGpPWpGaD
Glipizide—Dizziness—Doxorubicin—hematologic cancer	2.63e-05	8.04e-05	CcSEcCtD
Glipizide—KCNJ11—Metabolism—GSTP1—hematologic cancer	2.6e-05	0.000262	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—AR—hematologic cancer	2.59e-05	0.000261	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	2.58e-05	0.00026	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	2.55e-05	0.000257	CbGpPWpGaD
Glipizide—Nausea—Epirubicin—hematologic cancer	2.55e-05	7.81e-05	CcSEcCtD
Glipizide—ABCC8—Metabolism—ABCB1—hematologic cancer	2.53e-05	0.000255	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ASNS—hematologic cancer	2.53e-05	0.000255	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—DCK—hematologic cancer	2.53e-05	0.000255	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—B3GAT1—hematologic cancer	2.53e-05	0.000255	CbGpPWpGaD
Glipizide—Vomiting—Doxorubicin—hematologic cancer	2.53e-05	7.73e-05	CcSEcCtD
Glipizide—Rash—Doxorubicin—hematologic cancer	2.5e-05	7.67e-05	CcSEcCtD
Glipizide—CYP3A4—Biological oxidations—GSTM1—hematologic cancer	2.5e-05	0.000252	CbGpPWpGaD
Glipizide—Dermatitis—Doxorubicin—hematologic cancer	2.5e-05	7.66e-05	CcSEcCtD
Glipizide—Headache—Doxorubicin—hematologic cancer	2.49e-05	7.62e-05	CcSEcCtD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	2.47e-05	0.000249	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTM1—hematologic cancer	2.47e-05	0.000249	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTM1—hematologic cancer	2.46e-05	0.000248	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—NCOR1—hematologic cancer	2.46e-05	0.000248	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ABCB1—hematologic cancer	2.46e-05	0.000248	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	2.44e-05	0.000246	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HDC—hematologic cancer	2.4e-05	0.000242	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—CDKN2B—hematologic cancer	2.39e-05	0.000241	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—NCOR1—hematologic cancer	2.39e-05	0.00024	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTM1—hematologic cancer	2.39e-05	0.00024	CbGpPWpGaD
Glipizide—Nausea—Doxorubicin—hematologic cancer	2.36e-05	7.23e-05	CcSEcCtD
Glipizide—PPARG—Metabolism—CD44—hematologic cancer	2.3e-05	0.000232	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NQO1—hematologic cancer	2.3e-05	0.000232	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NCOR1—hematologic cancer	2.27e-05	0.000228	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.25e-05	0.000227	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	2.24e-05	0.000225	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CDA—hematologic cancer	2.19e-05	0.000221	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYCS—hematologic cancer	2.18e-05	0.000219	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—MTHFR—hematologic cancer	2.17e-05	0.000219	CbGpPWpGaD
Glipizide—PPARG—Metabolism—HSP90AA1—hematologic cancer	2.16e-05	0.000218	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PC—hematologic cancer	2.11e-05	0.000213	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—MTHFR—hematologic cancer	2.11e-05	0.000212	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NR3C1—hematologic cancer	2.1e-05	0.000211	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PHYH—hematologic cancer	2.09e-05	0.00021	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GMPS—hematologic cancer	2.09e-05	0.00021	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—FTCD—hematologic cancer	2.09e-05	0.00021	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—EP300—hematologic cancer	2.08e-05	0.000209	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GBA—hematologic cancer	2.04e-05	0.000206	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC35B2—hematologic cancer	2.04e-05	0.000206	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—SRC—hematologic cancer	2.02e-05	0.000204	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—hematologic cancer	1.97e-05	0.000198	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—STAT3—hematologic cancer	1.95e-05	0.000196	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.95e-05	0.000196	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—NRAS—hematologic cancer	1.94e-05	0.000196	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—MYC—hematologic cancer	1.92e-05	0.000194	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTP1—hematologic cancer	1.92e-05	0.000193	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.91e-05	0.000192	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTAP—hematologic cancer	1.87e-05	0.000188	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MAPK3—hematologic cancer	1.86e-05	0.000188	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.86e-05	0.000187	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CG—hematologic cancer	1.83e-05	0.000184	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ABCB1—hematologic cancer	1.82e-05	0.000183	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MAPK14—hematologic cancer	1.82e-05	0.000183	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TGFB1—hematologic cancer	1.81e-05	0.000182	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—ESR1—hematologic cancer	1.78e-05	0.000179	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CG—hematologic cancer	1.77e-05	0.000179	CbGpPWpGaD
Glipizide—PPARG—Metabolism—NCOR1—hematologic cancer	1.76e-05	0.000178	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTM1—hematologic cancer	1.76e-05	0.000178	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—NOTCH1—hematologic cancer	1.72e-05	0.000174	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CREBBP—hematologic cancer	1.69e-05	0.000171	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—TNF—hematologic cancer	1.69e-05	0.00017	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—KRAS—hematologic cancer	1.67e-05	0.000169	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ASNS—hematologic cancer	1.67e-05	0.000168	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.67e-05	0.000168	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—DCK—hematologic cancer	1.67e-05	0.000168	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—FHL2—hematologic cancer	1.66e-05	0.000168	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CREBBP—hematologic cancer	1.64e-05	0.000166	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AGRN—hematologic cancer	1.63e-05	0.000164	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CD—hematologic cancer	1.61e-05	0.000162	CbGpPWpGaD
Glipizide—KCNJ11—hematopoietic system—hematologic cancer	1.59e-05	0.172	CbGeAlD
Glipizide—ABCC8—Metabolism—ALB—hematologic cancer	1.58e-05	0.00016	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HDC—hematologic cancer	1.58e-05	0.000159	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—CREBBP—hematologic cancer	1.56e-05	0.000157	CbGpPWpGaD
Glipizide—PPARG—Metabolism—MTHFR—hematologic cancer	1.56e-05	0.000157	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CD—hematologic cancer	1.56e-05	0.000157	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HMMR—hematologic cancer	1.55e-05	0.000156	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—IDH2—hematologic cancer	1.55e-05	0.000156	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALB—hematologic cancer	1.54e-05	0.000155	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3R1—hematologic cancer	1.52e-05	0.000153	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3R1—hematologic cancer	1.47e-05	0.000148	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.46e-05	0.000147	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ARNTL—hematologic cancer	1.45e-05	0.000146	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CDA—hematologic cancer	1.45e-05	0.000146	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—HRAS—hematologic cancer	1.42e-05	0.000143	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ACP5—hematologic cancer	1.41e-05	0.000143	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CA9—hematologic cancer	1.41e-05	0.000143	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CB—hematologic cancer	1.4e-05	0.000141	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NCOR2—hematologic cancer	1.4e-05	0.000141	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PC—hematologic cancer	1.39e-05	0.00014	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.37e-05	0.000138	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—IL6—hematologic cancer	1.36e-05	0.000137	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CB—hematologic cancer	1.36e-05	0.000137	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GBA—hematologic cancer	1.35e-05	0.000136	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC35B2—hematologic cancer	1.35e-05	0.000136	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—IDH1—hematologic cancer	1.33e-05	0.000134	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTO1—hematologic cancer	1.31e-05	0.000132	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—TXN—hematologic cancer	1.31e-05	0.000132	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCC3—hematologic cancer	1.31e-05	0.000132	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CG—hematologic cancer	1.31e-05	0.000132	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SPHK1—hematologic cancer	1.29e-05	0.00013	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—AKT1—hematologic cancer	1.26e-05	0.000127	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—UGT1A1—hematologic cancer	1.24e-05	0.000125	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTAP—hematologic cancer	1.23e-05	0.000124	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CREBBP—hematologic cancer	1.21e-05	0.000122	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTEN—hematologic cancer	1.21e-05	0.000122	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CRABP1—hematologic cancer	1.2e-05	0.000121	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC22A1—hematologic cancer	1.2e-05	0.000121	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTEN—hematologic cancer	1.17e-05	0.000118	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALOX5—hematologic cancer	1.17e-05	0.000118	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—EP300—hematologic cancer	1.15e-05	0.000116	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CD—hematologic cancer	1.15e-05	0.000116	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALB—hematologic cancer	1.14e-05	0.000114	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NUP98—hematologic cancer	1.13e-05	0.000114	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—EP300—hematologic cancer	1.12e-05	0.000113	CbGpPWpGaD
Glipizide—PPARG—hematopoietic system—hematologic cancer	1.12e-05	0.121	CbGeAlD
Glipizide—CYP2C9—Metabolism—ADCY7—hematologic cancer	1.1e-05	0.000111	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NCOA3—hematologic cancer	1.1e-05	0.000111	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—FHL2—hematologic cancer	1.1e-05	0.000111	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NUP214—hematologic cancer	1.09e-05	0.00011	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3R1—hematologic cancer	1.09e-05	0.00011	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.08e-05	0.000109	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AGRN—hematologic cancer	1.08e-05	0.000108	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTR—hematologic cancer	1.07e-05	0.000108	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCG2—hematologic cancer	1.07e-05	0.000108	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ENO2—hematologic cancer	1.05e-05	0.000106	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—IDH2—hematologic cancer	1.02e-05	0.000103	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HMMR—hematologic cancer	1.02e-05	0.000103	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTT1—hematologic cancer	1.02e-05	0.000103	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1e-05	0.000101	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CB—hematologic cancer	1e-05	0.000101	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SDC1—hematologic cancer	9.96e-06	0.0001	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ARNTL—hematologic cancer	9.58e-06	9.66e-05	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MAPK3—hematologic cancer	9.52e-06	9.6e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	9.51e-06	9.59e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	9.39e-06	9.47e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CA9—hematologic cancer	9.32e-06	9.4e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ACP5—hematologic cancer	9.32e-06	9.4e-05	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MYC—hematologic cancer	9.26e-06	9.34e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NCOR2—hematologic cancer	9.2e-06	9.28e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	8.98e-06	9.06e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—IDH1—hematologic cancer	8.77e-06	8.84e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTO1—hematologic cancer	8.67e-06	8.74e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCC3—hematologic cancer	8.67e-06	8.74e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—TXN—hematologic cancer	8.67e-06	8.74e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTEN—hematologic cancer	8.67e-06	8.74e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CA—hematologic cancer	8.53e-06	8.6e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SPHK1—hematologic cancer	8.48e-06	8.55e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CD44—hematologic cancer	8.47e-06	8.54e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—NQO1—hematologic cancer	8.47e-06	8.54e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	8.29e-06	8.36e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CA—hematologic cancer	8.27e-06	8.34e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—EP300—hematologic cancer	8.26e-06	8.33e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—UGT1A1—hematologic cancer	8.15e-06	8.21e-05	CbGpPWpGaD
Glipizide—ABCC8—testis—hematologic cancer	8.02e-06	0.087	CbGeAlD
Glipizide—CYP2C9—Metabolism—CYCS—hematologic cancer	8.01e-06	8.08e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	7.96e-06	8.03e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CRABP1—hematologic cancer	7.93e-06	7.99e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC22A1—hematologic cancer	7.93e-06	7.99e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALOX5—hematologic cancer	7.73e-06	7.79e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NUP98—hematologic cancer	7.48e-06	7.54e-05	CbGpPWpGaD
Glipizide—PPARG—blood—hematologic cancer	7.4e-06	0.0803	CbGeAlD
Glipizide—CYP3A4—Metabolism—ADCY7—hematologic cancer	7.26e-06	7.32e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NCOA3—hematologic cancer	7.26e-06	7.32e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NUP214—hematologic cancer	7.21e-06	7.27e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	7.17e-06	7.22e-05	CbGpPWpGaD
Glipizide—PPARG—bone marrow—hematologic cancer	7.16e-06	0.0777	CbGeAlD
Glipizide—CYP3A4—Metabolism—MTR—hematologic cancer	7.07e-06	7.12e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCG2—hematologic cancer	7.07e-06	7.12e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTP1—hematologic cancer	7.06e-06	7.12e-05	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—AKT1—hematologic cancer	6.97e-06	7.02e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ENO2—hematologic cancer	6.93e-06	6.98e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	6.83e-06	6.89e-05	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—AKT1—hematologic cancer	6.76e-06	6.81e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTT1—hematologic cancer	6.72e-06	6.77e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCB1—hematologic cancer	6.69e-06	6.74e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SDC1—hematologic cancer	6.57e-06	6.62e-05	CbGpPWpGaD
Glipizide—CYP2C9—hematopoietic system—hematologic cancer	6.54e-06	0.071	CbGeAlD
Glipizide—CYP2C9—Metabolism—NCOR1—hematologic cancer	6.49e-06	6.54e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTM1—hematologic cancer	6.49e-06	6.54e-05	CbGpPWpGaD
Glipizide—PPARG—lung—hematologic cancer	6.49e-06	0.0704	CbGeAlD
Glipizide—PPARG—Gene Expression—AKT1—hematologic cancer	6.42e-06	6.47e-05	CbGpPWpGaD
Glipizide—KCNJ11—lymph node—hematologic cancer	6.31e-06	0.0685	CbGeAlD
Glipizide—PPARG—testis—hematologic cancer	6.12e-06	0.0664	CbGeAlD
Glipizide—PPARG—Metabolism—PIK3CA—hematologic cancer	6.11e-06	6.16e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—MTHFR—hematologic cancer	5.74e-06	5.78e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—NQO1—hematologic cancer	5.59e-06	5.63e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CD44—hematologic cancer	5.59e-06	5.63e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYCS—hematologic cancer	5.29e-06	5.33e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	5.25e-06	5.29e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	5.06e-06	5.1e-05	CbGpPWpGaD
Glipizide—PPARG—Metabolism—AKT1—hematologic cancer	4.99e-06	5.03e-05	CbGpPWpGaD
Glipizide—CYP3A4—hematopoietic system—hematologic cancer	4.99e-06	0.0541	CbGeAlD
Glipizide—CYP2C9—Metabolism—PIK3CG—hematologic cancer	4.82e-06	4.86e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTP1—hematologic cancer	4.66e-06	4.7e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CREBBP—hematologic cancer	4.47e-06	4.5e-05	CbGpPWpGaD
Glipizide—PPARG—lymph node—hematologic cancer	4.44e-06	0.0481	CbGeAlD
Glipizide—CYP3A4—Metabolism—ABCB1—hematologic cancer	4.41e-06	4.45e-05	CbGpPWpGaD
Glipizide—CYP2C9—blood—hematologic cancer	4.34e-06	0.047	CbGeAlD
Glipizide—CYP3A4—Metabolism—NCOR1—hematologic cancer	4.28e-06	4.32e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTM1—hematologic cancer	4.28e-06	4.32e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CD—hematologic cancer	4.24e-06	4.27e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALB—hematologic cancer	4.18e-06	4.22e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3R1—hematologic cancer	4e-06	4.03e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—MTHFR—hematologic cancer	3.78e-06	3.81e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CB—hematologic cancer	3.69e-06	3.72e-05	CbGpPWpGaD
Glipizide—CYP3A4—blood—hematologic cancer	3.31e-06	0.0358	CbGeAlD
Glipizide—CYP2C9—Metabolism—PTEN—hematologic cancer	3.19e-06	3.22e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CG—hematologic cancer	3.18e-06	3.2e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—EP300—hematologic cancer	3.04e-06	3.07e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CREBBP—hematologic cancer	2.95e-06	2.97e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CD—hematologic cancer	2.79e-06	2.82e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALB—hematologic cancer	2.76e-06	2.78e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3R1—hematologic cancer	2.64e-06	2.66e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CB—hematologic cancer	2.44e-06	2.46e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CA—hematologic cancer	2.25e-06	2.27e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTEN—hematologic cancer	2.1e-06	2.12e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—EP300—hematologic cancer	2.01e-06	2.02e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—AKT1—hematologic cancer	1.84e-06	1.85e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CA—hematologic cancer	1.48e-06	1.5e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—AKT1—hematologic cancer	1.21e-06	1.22e-05	CbGpPWpGaD
